- Home
- DCOM vs LENZ Comparison
DCOM vs LENZ Comparison
Compare DCOM & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCOM
- LENZ
- Stock Information
- Founded
- DCOM 1864
- LENZ 2019
- Country
- DCOM United States
- LENZ United States
- Employees
- DCOM N/A
- LENZ N/A
- Industry
- DCOM Major Banks
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- DCOM Finance
- LENZ Health Care
- Exchange
- DCOM Nasdaq
- LENZ Nasdaq
- Market Cap
- DCOM 1.2B
- LENZ 1.2B
- IPO Year
- DCOM 1996
- LENZ 2021
- Fundamental
- Price
- DCOM $27.78
- LENZ $38.28
- Analyst Decision
- DCOM Buy
- LENZ Strong Buy
- Analyst Count
- DCOM 2
- LENZ 4
- Target Price
- DCOM $36.75
- LENZ $53.75
- AVG Volume (30 Days)
- DCOM 177.7K
- LENZ 872.3K
- Earning Date
- DCOM 10-23-2025
- LENZ 11-05-2025
- Dividend Yield
- DCOM 3.59%
- LENZ N/A
- EPS Growth
- DCOM N/A
- LENZ N/A
- EPS
- DCOM 0.87
- LENZ N/A
- Revenue
- DCOM $314,165,000.00
- LENZ $5,000,000.00
- Revenue This Year
- DCOM $49.66
- LENZ N/A
- Revenue Next Year
- DCOM $16.29
- LENZ $285.82
- P/E Ratio
- DCOM $31.81
- LENZ N/A
- Revenue Growth
- DCOM N/A
- LENZ N/A
- 52 Week Low
- DCOM $23.25
- LENZ $16.54
- 52 Week High
- DCOM $37.60
- LENZ $50.40
- Technical
- Relative Strength Index (RSI)
- DCOM 35.20
- LENZ 42.00
- Support Level
- DCOM $27.58
- LENZ $37.00
- Resistance Level
- DCOM $30.56
- LENZ $42.98
- Average True Range (ATR)
- DCOM 0.98
- LENZ 3.05
- MACD
- DCOM -0.28
- LENZ -1.06
- Stochastic Oscillator
- DCOM 7.12
- LENZ 10.65
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.